Gene Page: CLN8
Summary ?
GeneID | 2055 |
Symbol | CLN8 |
Synonyms | C8orf61|EPMR |
Description | ceroid-lipofuscinosis, neuronal 8 |
Reference | MIM:607837|HGNC:HGNC:2079|Ensembl:ENSG00000182372|HPRD:06383|Vega:OTTHUMG00000090343 |
Gene type | protein-coding |
Map location | 8p23 |
Pascal p-value | 0.756 |
Sherlock p-value | 0.334 |
Fetal beta | -0.477 |
DMG | 1 (# studies) |
eGene | Cerebellum Myers' cis & trans Meta |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Wockner_2014 | Genome-wide DNA methylation analysis | This dataset includes 4641 differentially methylated probes corresponding to 2929 unique genes between schizophrenia patients (n=24) and controls (n=24). | 1 |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 3 |
Section I. Genetics and epigenetics annotation
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg17927889 | 8 | 1733497 | CLN8 | 8.75E-6 | -0.401 | 0.013 | DMG:Wockner_2014 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs270917 | chr2 | 161607017 | CLN8 | 2055 | 0.01 | trans | ||
rs270916 | chr2 | 161607046 | CLN8 | 2055 | 0.01 | trans | ||
rs270909 | chr2 | 161610477 | CLN8 | 2055 | 0.09 | trans | ||
rs270914 | chr2 | 161611917 | CLN8 | 2055 | 0.01 | trans | ||
rs270996 | chr2 | 161670759 | CLN8 | 2055 | 0.04 | trans | ||
rs271001 | chr2 | 161674742 | CLN8 | 2055 | 0.05 | trans | ||
rs7595584 | chr2 | 175652187 | CLN8 | 2055 | 0.05 | trans | ||
snp_a-1882582 | 0 | CLN8 | 2055 | 0.14 | trans | |||
rs9965053 | chr18 | 3166191 | CLN8 | 2055 | 0.16 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
CIT | 0.80 | 0.76 |
C3orf57 | 0.79 | 0.66 |
SGPP2 | 0.79 | 0.72 |
INPP4B | 0.78 | 0.74 |
EMB | 0.77 | 0.66 |
WNT2 | 0.77 | 0.62 |
KCNC2 | 0.77 | 0.65 |
MCF2 | 0.77 | 0.61 |
PHACTR2 | 0.76 | 0.63 |
BTBD11 | 0.76 | 0.75 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
WDR86 | -0.39 | -0.46 |
PLEKHO1 | -0.39 | -0.46 |
NR2C2AP | -0.37 | -0.44 |
RPL18 | -0.36 | -0.61 |
EMID1 | -0.36 | -0.45 |
RPL12 | -0.36 | -0.53 |
RPS19P3 | -0.36 | -0.61 |
RPL14 | -0.36 | -0.47 |
TRAF4 | -0.36 | -0.54 |
RPLP1 | -0.36 | -0.53 |
Section III. Gene Ontology annotation
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0051935 | glutamate uptake during transmission of nerve impulse | IEA | neuron, glutamate, Neurotransmitter, Glial (GO term level: 11) | - |
GO:0021522 | spinal cord motor neuron differentiation | IEA | neuron, Brain (GO term level: 9) | - |
GO:0007399 | nervous system development | IMP | neurite (GO term level: 5) | 10508524 |
GO:0001306 | age-dependent response to oxidative stress | IEA | - | |
GO:0007006 | mitochondrial membrane organization | IEA | - | |
GO:0008203 | cholesterol metabolic process | IMP | 16086686 | |
GO:0008306 | associative learning | IEA | - | |
GO:0008610 | lipid biosynthetic process | NAS | 12151215 | |
GO:0008361 | regulation of cell size | IEA | - | |
GO:0007628 | adult walking behavior | IEA | - | |
GO:0007040 | lysosome organization | IEA | - | |
GO:0006644 | phospholipid metabolic process | IMP | 16086686 | |
GO:0006869 | lipid transport | NAS | 12151215 | |
GO:0043066 | negative regulation of apoptosis | IEA | - | |
GO:0050885 | neuromuscular process controlling balance | IEA | - | |
GO:0050881 | musculoskeletal movement | IEA | - | |
GO:0051348 | negative regulation of transferase activity | IEA | - | |
GO:0035176 | social behavior | IEA | - | |
GO:0045861 | negative regulation of proteolysis | NAS | 12151215 | |
GO:0050884 | neuromuscular process controlling posture | IEA | - | |
GO:0044257 | cellular protein catabolic process | IEA | - | |
GO:0046513 | ceramide biosynthetic process | NAS | 12151215 | |
GO:0045494 | photoreceptor cell maintenance | IEA | - | |
GO:0060041 | retina development in camera-type eye | IEA | - | |
GO:0060052 | neurofilament cytoskeleton organization | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005789 | endoplasmic reticulum membrane | IEA | - | |
GO:0005783 | endoplasmic reticulum | IDA | 10861296 | |
GO:0016020 | membrane | IEA | - | |
GO:0016021 | integral to membrane | NAS | 10508524 |10861296 | |
GO:0033116 | ER-Golgi intermediate compartment membrane | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP | 285 | 181 | All SZGR 2.0 genes in this pathway |
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP | 579 | 346 | All SZGR 2.0 genes in this pathway |
THUM SYSTOLIC HEART FAILURE DN | 244 | 147 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER EARLY UP | 430 | 232 | All SZGR 2.0 genes in this pathway |
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP | 158 | 103 | All SZGR 2.0 genes in this pathway |
MULLIGHAN NPM1 MUTATED SIGNATURE 1 UP | 276 | 165 | All SZGR 2.0 genes in this pathway |
MULLIGHAN NPM1 SIGNATURE 3 UP | 341 | 197 | All SZGR 2.0 genes in this pathway |
PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
MOHANKUMAR TLX1 TARGETS UP | 414 | 287 | All SZGR 2.0 genes in this pathway |
KANG IMMORTALIZED BY TERT UP | 89 | 61 | All SZGR 2.0 genes in this pathway |
MCCLUNG DELTA FOSB TARGETS 2WK | 48 | 36 | All SZGR 2.0 genes in this pathway |
BILD CTNNB1 ONCOGENIC SIGNATURE | 82 | 52 | All SZGR 2.0 genes in this pathway |
ACEVEDO METHYLATED IN LIVER CANCER DN | 940 | 425 | All SZGR 2.0 genes in this pathway |
BOCHKIS FOXA2 TARGETS | 425 | 261 | All SZGR 2.0 genes in this pathway |
CHEN METABOLIC SYNDROM NETWORK | 1210 | 725 | All SZGR 2.0 genes in this pathway |
WANG METASTASIS OF BREAST CANCER ESR1 DN | 30 | 18 | All SZGR 2.0 genes in this pathway |
WANG RESPONSE TO GSK3 INHIBITOR SB216763 UP | 397 | 206 | All SZGR 2.0 genes in this pathway |
DUTERTRE ESTRADIOL RESPONSE 24HR DN | 505 | 328 | All SZGR 2.0 genes in this pathway |
PANGAS TUMOR SUPPRESSION BY SMAD1 AND SMAD5 DN | 157 | 106 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE EARLY LATE | 317 | 190 | All SZGR 2.0 genes in this pathway |
FEVR CTNNB1 TARGETS UP | 682 | 433 | All SZGR 2.0 genes in this pathway |
GOBERT OLIGODENDROCYTE DIFFERENTIATION DN | 1080 | 713 | All SZGR 2.0 genes in this pathway |
DELACROIX RAR BOUND ES | 462 | 273 | All SZGR 2.0 genes in this pathway |
PEDRIOLI MIR31 TARGETS DN | 418 | 245 | All SZGR 2.0 genes in this pathway |